Main competitors
Revenues (N-1) Net Margin (N-1) EBIT Margin (N-1) ROE (N-1) ROA (N-1) Leverage (N-1)
1.5B 9.91%16.02%8.45%5.51% -
24.78B 12.36%17.06%12.27%5.26%1.32x
1.4B 22.69%33.58%153.59% - 3.59x
3.15B 12.08%19.25%7.1%7.97%-2.04x
371M 43.96%17.59%50.72%27.36%-1.97x
1.4B 3.42%2.65%3.41%2.46%-0.38x
719M -5.36%22.07%12.89% - -
396M 13.92%13.83%7.43%4.35%2.4x
90.14M -17.41%-27.13%-6.97%-3.55% -
23.02M 2.58%-7.8%-1.29%-0.96%107.21x
4.02M -2,716.67%-2,773.81% - - -
518M 3.27%4.21%3.46%2.12% -
590M 13.54%6.54%5.6%2.76%-4.56x
168M 19.44%21.61%5.79%4.65% -
Average 2.51B -184.45% -188.17% 20.19% 5.27% 13.20x
Weighted average by Cap. 14.7B -22.93% -20.41% 24.13% 6.3% 2.47x
Specialty & Advanced Pharmaceuticals
SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW